Lars Andreas Rømo Ystaas

Dr. Lars Andreas Rømo Ystaas

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ESEge Solel
Ege Solel
EBEgil Brudvik
Egil Brudvik
LYLars Andreas Rømo Ystaas
Lars Andreas Rømo Ystaas
YYYahaya A. Yabo
Yahaya A. Yabo
EREmma Rigg
Emma Rigg
HMHrvoje Miletic
Hrvoje Miletic
Treatment of glioblastoma (GB), the most common and most aggressive malignant brain tumor, has made little progress over the past two decades. Despite extensive research on apoptosis and autophagy, necrotic cell death mechanisms like pyroptosis, which have the potential to stimulate anti-tumor immune responses, remain largely underexplored in GB. Here, we investigated whether Gasdermin E (GSDME)-mediated pyroptosis can be induced in GB by employing the drug raptinal, an inducer of cytochrome c release. Using human patient-derived and mouse GB cell lines, we showed that raptinal promotes GSMDE cleavage. However, although a strong pyroptotic response was observed in mouse cell lines, it was weak in human cell lines. This resistance was partially reversed by the calcium chelator BAPTA-AM, indicating that membrane repair mechanisms may counteract the pyroptotic response. Gsdme knockout (KO) in mouse GB cells unexpectedly prolonged the survival of immunocompetent mice, demonstrating a tumor-promoting role of GSDME independent of its pyroptotic function. Analysis of the immune microenvironment revealed that Gsdme KO promoted infiltration of T cells, which was confirmed by spatial transcriptomic analysis of GB patient samples. In addition, Gsdme/GSMDE KO reduced the invasive capacity of mouse/human GB cells. In conclusion, active membrane repair mechanisms may impair the pyroptotic efficacy in GB. GSDME has a tumor-promoting role in GB by suppressing T cell infiltration and increasing tumor cell invasion.

30 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JKJ. Kopal
J. Kopal
NBN.R. Bakken
N.R. Bakken
PPP. Parekh
P. Parekh
ASA.A. Shadrin
A.A. Shadrin
PJP. Jaholkowski
P. Jaholkowski
OAO.A. Andreassen
O.A. Andreassen
Early-childhood temperament is associated with mental health outcomes decades later. Temperament reflects early-emerging individual differences in emotional and behavioral tendencies. These differences are relatively stable across development and shaped by both genetic and environmental influences. However, the consequences of departures from expected developmental trajectories remain largely unexplored. Using data from more than 50,000 children in the Norwegian Mother, Father and Child Cohort Study, we modeled longitudinal temperament trajectories at 1.5, 3, and 5 years of age and quantified deviations from expected development. Multivariate pattern analysis revealed latent dimensions linking these deviations to clinical diagnoses, with ADHD as the most prominent outcome. Time-to-event analysis showed that these dimensions were associated with a higher hazard of ADHD diagnosis across childhood and adolescence. Finally, genetic analyses identified loci jointly associated with temperament trajectories and ADHD, revealing age-dependent genetic effects. Together, these findings show that deviations from temperament trajectories in early childhood capture transdiagnostic vulnerability across development. Early temperament monitoring may thus serve as an indicator of later mental health risk.

22 January 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JAJohannes K. Andersen
Johannes K. Andersen
LYLars Andreas Rømo Ystaas
Lars Andreas Rømo Ystaas
RBRolf Bjerkvig
Rolf Bjerkvig
HMHrvoje Miletic
Hrvoje Miletic
JHJubayer A. Hossain
Jubayer A. Hossain
Background: Lentiviral vectors (LVs) show promise as gene therapy tools for brain tumors, but optimal envelope protein choices for different tumor types have not been determined. Methodology: This study evaluated three pseudotyped LV variants—VSV-GP, FuG-B2, and LCMV-GP—across diverse brain tumor cell lines including glioblastoma (GBM), diffuse intrinsic pontine glioma (DIPG), medulloblastoma, and metastatic brain cancers. Results: VSV-GP and FuG-B2 pseudotypes significantly outperformed LCMV-GP across most tumor types. Both VSV-GP and FuG-B2 demonstrated high transduction efficiency in GBM and DIPG cells, though some cell lines displayed selective preferences for one pseudotype over the other. Medulloblastoma cells were challenging to transduce, with only VSV-GP achieving substantial efficacy. Metastatic brain cancers showed distinct tropism patterns: melanoma metastases were preferentially transduced by the FuG-B2 pseudotype, while lung metastases showed preference for the VSV-GP pseudotype. Conclusions: These findings suggest envelope protein selection should be tailored to specific brain tumor types. VSV-GP appears most suitable for medulloblastoma and lung metastases, FuG-B2 for melanoma metastases, and both for GBM and DIPG gene therapy applications. The study provides crucial guidance for translating lentiviral gene therapy to clinical applications, supporting personalized treatment strategies based on tumor-specific vector tropism profiles.

11 September 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JKJ. Kopal
J. Kopal
NBN. R. Bakken
N. R. Bakken
PPP. Parekh
P. Parekh
ASA. A. Shadrin
A. A. Shadrin
PJP. Jaholkowski
P. Jaholkowski
OAO. A. Andreassen
O. A. Andreassen
Early-childhood temperament is associated with later mental health. Temperament continues to develop throughout the first years of life, and a single assessment cannot capture its trajectory. Whether departures from an individual’s developmental trajectory carry psychiatric risk remains unknown. Using data from more than 50,000 children in the Norwegian Mother, Father and Child Cohort Study, we modeled longitudinal temperament at 1.5, 3, and 5 years of age with the FEMA-Long mixed-effects framework. We then quantified each child’s departures from their predicted trajectories. Multivariate analysis revealed two transdiagnostic dimensions linking trajectory departures to psychiatric diagnoses across childhood and adolescence. Higher scores on the first dimension were associated with an increased hazard of subsequent ADHD diagnosis (hazard ratio = 1.54), and higher scores on the second with an increased hazard of Asperger syndrome (hazard ratio = 1.64). To examine the genetic basis of these associations, we performed longitudinal GWAS of temperament and conjunctional FDR analysis to detect loci shared with the associated diagnoses. The effects of these loci changed across early childhood, with some strengthening and others attenuating with age. These findings show that departures from predicted temperament trajectories reflect transdiagnostic psychiatric risk with a shared genetic basis. Longitudinal, trajectory-based monitoring could help identify children at elevated psychiatric risk.

5 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
LYLars Andreas Rømo Ystaas
Lars Andreas Rømo Ystaas
PPPravesh Parekh
Pravesh Parekh
NPNadine Parker
Nadine Parker
IAIbrahim Akkouh
Ibrahim Akkouh
VBViktoria Birkenæs
Viktoria Birkenæs
KOKevin O'Connell
Kevin O'Connell
Background: Bipolar disorder (BIP) frequently co-occurs with heightened substance use (SU) and substance use disorders (SUDs). Although the strong co-occurrence of these heritable traits points to shared genetic susceptibility, the extent to which there are differences in how SU and SUD overlap with BIP genetic architecture remains unclear. Methods: We quantified the polygenic overlap between BIP and SUDs (alcohol, cannabis, opioid, and tobacco), and BIP and SU traits (drinks per week, lifetime cannabis use, prescription_opioid use, and smoking initiation) using GWAS summary statistics and trivariate MiXeR. We then isolated the general and unique genetic contributions of SUD and SU using GWAS-by-subtraction via GenomicSEM. Next, we tested associations between polygenic risk scores (PRSs) derived from these latent factors and diagnostic and behavioral outcomes in the Norwegian Mother, Father and Child Cohort Study. Finally, we applied GSA-MiXeR to explore pleiotropic pathway enrichment shared between the latent factors and BIP. Results: We found extensive polygenic overlap between traits, with SUDs being more genetically correlated with BIP than SU traits. The unique SUD factor correlated positively with psychiatric disorders, whereas unique SU correlated negatively. PRSs for BIP, shared SUD/SU, and unique SUD were significantly associated with BIP, SUD, and comorbid SUD-BIP; PRS for unique SU was only associated with self-reported lifetime SU. GSA-MiXeR revealed richer gene-set enrichment for SUD/BIP than SU/BIP implicating dopamine signaling and interneuron function. Conclusion: By dissecting the genetic liability to SUD and SU and investigating their relationship with BIP we find a genetic link driven by substance dependence but not substance use more broadly.

24 August 2026 in Biological Psychiatry
Verified
Journal Article
Open access
LYLars Andreas Rømo Ystaas
Lars Andreas Rømo Ystaas
PPPravesh Parekh
Pravesh Parekh
NPNadine Parker
Nadine Parker
IAIbrahim Akkouh
Ibrahim Akkouh
VBViktoria Birkenæs
Viktoria Birkenæs
KOKevin O'Connell
Kevin O'Connell